Ou Y - Search Results

1

Dark horse target Claudin18.2 opens new battlefield for pancreatic cancer.

Xu Q, Jia C, Ou Y, Zeng C, Jia Y. Xu Q, et al. Among authors: ou y. Front Oncol. 2024 Mar 6;14:1371421. doi: 10.3389/fonc.2024.1371421. eCollection 2024. Front Oncol. 2024. PMID: 38511141 Free PMC article. Review.

2

Research progress of targeted therapy combined with immunotherapy for hepatocellular carcinoma.

Xie S, Wang M, Zeng C, Ou Y, Zhao L, Wang D, Chen L, Kong F, Yi D. Xie S, et al. Among authors: ou y. Front Oncol. 2023 May 25;13:1197698. doi: 10.3389/fonc.2023.1197698. eCollection 2023. Front Oncol. 2023. PMID: 37305582 Free PMC article. Review.

3

Synergist for antitumor therapy: Astragalus polysaccharides acting on immune microenvironment.

Xu Q, Cheng W, Wei J, Ou Y, Xiao X, Jia Y. Xu Q, et al. Among authors: ou y. Discov Oncol. 2023 Sep 24;14(1):179. doi: 10.1007/s12672-023-00798-w. Discov Oncol. 2023. PMID: 37741920 Free PMC article. Review.

4

Corrigendum: Research progress of targeted therapy combined with immunotherapy for hepatocellular carcinoma.

Xie S, Wang M, Zeng C, Ou Y, Zhao L, Wang D, Chen L, Kong F, Yi D. Xie S, et al. Among authors: ou y. Front Oncol. 2023 Dec 13;13:1338060. doi: 10.3389/fonc.2023.1338060. eCollection 2023. Front Oncol. 2023. PMID: 38162493 Free PMC article.

5

Small molecule agents for triple negative breast cancer: Current status and future prospects.

Ou Y, Wang M, Xu Q, Sun B, Jia Y. Ou Y, et al. Transl Oncol. 2024 Mar;41:101893. doi: 10.1016/j.tranon.2024.101893. Epub 2024 Jan 29. Transl Oncol. 2024. PMID: 38290250 Free PMC article. Review.

6

Genetically predicted 486 blood metabolites in relation to risk of esophageal cancer: a Mendelian randomization study.

Jia C, Yi D, Ma M, Xu Q, Ou Y, Kong F, Jia Y. Jia C, et al. Among authors: ou y. Front Mol Biosci. 2024 Oct 2;11:1391419. doi: 10.3389/fmolb.2024.1391419. eCollection 2024. Front Mol Biosci. 2024. PMID: 39417005 Free PMC article.

7

Prognostic value of inflammatory markers NLR, PLR, LMR, dNLR, ANC in melanoma patients treated with immune checkpoint inhibitors: a meta-analysis and systematic review.

Ou Y, Liang S, Gao Q, Shang Y, Liang J, Zhang W, Liu S. Ou Y, et al. Front Immunol. 2024 Oct 18;15:1482746. doi: 10.3389/fimmu.2024.1482746. eCollection 2024. Front Immunol. 2024. PMID: 39493767 Free PMC article.

8

Preventive effects of chemical drugs on recurrence of colorectal adenomas: systematic review and Bayesian network meta-analysis.

Tan S, Ou Y, Yang Y, Huang S, Chen S, Gao Q. Tan S, et al. Among authors: ou y. Eur J Gastroenterol Hepatol. 2024 Jan 1;36(1):62-75. doi: 10.1097/MEG.0000000000002676. Eur J Gastroenterol Hepatol. 2024. PMID: 37942763

9

Surgical, oncological, and functional outcomes of local and radical resection after neoadjuvant chemotherapy or chemoradiotherapy for early- and mid-stage rectal cancer: a systematic review and meta-analysis.

Tan S, Ou Y, Huang S, Gao Q. Tan S, et al. Among authors: ou y. Int J Colorectal Dis. 2023 May 16;38(1):132. doi: 10.1007/s00384-023-04433-6. Int J Colorectal Dis. 2023. PMID: 37193915 Review.

10

Risk and incidence of colorectal stricture progressing to colorectal neoplasia in patients with inflammatory bowel disease: a systematic review and meta-analysis.

Zhan Y, Cheng X, Mei P, Wu J, Ou Y, Cui Y. Zhan Y, et al. Among authors: ou y. Eur J Gastroenterol Hepatol. 2023 Oct 1;35(10):1075-1087. doi: 10.1097/MEG.0000000000002614. Epub 2023 Jul 31. Eur J Gastroenterol Hepatol. 2023. PMID: 37577790

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,290 results

Search Page

Filters